global glp-1 market size 2025 Obesity GLP-1 Agonists Market Exclusive Research

A significant improvement in sleep quality was noted in the prebiotic group, with a significant decrease in depression, anxiety, and stress in all three groups

The BMJ analysis projected cardiometabolic markers to trend back toward baseline after cessation

Slowing gastric emptying and reducing appetite Decreasing postprandial and fasting glucose, as well as serum triglycerides Pharmacokinetics Synthetic GLP-1 agonists are resistant to degradation by DPP-4 , giving them a longer half-life than endogenous GLP-1

Individuals who have tried dieting and exercise alone without seeing the results they want may also benefit from the enhanced metabolic support